Search Results - "Stouthard, J"

Possible alleviation of symptoms and side effects through clinicians’ nocebo information and empathy in an experimental video vignette study by Meijers, M. C., Stouthard, J., Evers, A. W. M., Das, E., Drooger, H. J., Jansen, S. J. A. J., Francke, A. L., Plum, N., van der Wall, E., Nestoriuc, Y., Dusseldorp, E., van Vliet, L. M.

“…To alleviate anti-cancer treatment burden in advanced breast cancer, patient-clinician communication strategies based on nocebo-effect mechanisms are…”
Get full text

Author Correction: Possible alleviation of symptoms and side effects through clinicians’ nocebo information and empathy in an experimental video vignette study by Meijers, M. C., Stouthard, J., Evers, A. W. M., Das, E., Drooger, H. J., Jansen, S. J. A. J., Francke, A. L., Plum, N., van der Wall, E., Nestoriuc, Y., Dusseldorp, E., van Vliet, L. M.

Get full text

Communication about Prognosis during Patient-Initiated Second Opinion Consultations in Advanced Cancer Care: An Observational Qualitative Analysis by van der Velden, N. C. A., van der Kleij, M. B. A., Lehmann, V., Smets, E. M. A., Stouthard, J. M. L., Henselmans, I., Hillen, M. A.

“…Prognostic communication is essential for patients with advanced cancer to enable informed medical decision-making and end-of-life planning. Discussing…”
Get full text

Gene expression profiles in circulating tumor cells to predict prognosis in metastatic breast cancer patients by Mostert, B., Sieuwerts, A.M., Kraan, J., Bolt-de Vries, J., van der Spoel, P., van Galen, A., Peeters, D.J., Dirix, L.Y., Seynaeve, C.M., Jager, A., de Jongh, F.E., Hamberg, P., Stouthard, J.M.L., Kehrer, D.F.S., Look, M.P., Smid, M., Gratama, J.W., Foekens, J.A., Martens, J.W.M., Sleijfer, S.

“…CTC characterization by a 16-gene profile identified from previously published CTC-specific genes detected poor prognosis metastatic breast cancer (MBC)…”
Get full text

Response to influenza virus vaccination during chemotherapy in patients with breast cancer by Meerveld-Eggink, A., de Weerdt, O., van der Velden, A.M.T., Los, M., van der Velden, A.W.G., Stouthard, J.M.L., Nijziel, M.R., Westerman, M., Beeker, A., van Beek, R., Rimmelzwaan, G.F., Rijkers, G.T., Biesma, D.H.

“…Patients receiving chemotherapy are at increased risk for influenza virus infection. Little is known about the preferred moment of vaccination during…”
Get full text

Influenza vaccination coverage in patients treated with chemotherapy: current clinical practice by Wumkes, M L, van der Velden, A M T, van der Velden, A W G, Stouthard, J M L, Nijziel, M R, Westerman, M, Beeker, A, Meerveld-Eggink, A, Rijkers, G T, Biesma, D H

“…Influenza virus vaccination is recommended for patients treated with chemotherapy. Little is known about vaccination coverage in these patients. Vaccination…”
Get full text

Risk estimations and treatment decisions in early stage breast cancer: Agreement among oncologists and the impact of the 70-gene signature by Drukker, C.A, van den Hout, H.C, Sonke, G.S, Brain, E, Bonnefoi, H, Cardoso, F, Goldhirsch, A, Harbeck, N, Honkoop, A.H, Koornstra, R.H.T, van Laarhoven, H.W.M, Portielje, J.E.A, Schneeweiss, A, Smorenburg, C.H, Stouthard, J, Linn, S.C, Schmidt, M.K

“…Abstract Background Clinical decision-making in patients with early stage breast cancer requires adequate risk estimation by medical oncologists. This survey…”
Get full text

Endocrinologic and metabolic effects of interleukin-6 in humans by Stouthard, J M, Romijn, J A, Van der Poll, T, Endert, E, Klein, S, Bakker, P J, Veenhof, C H, Sauerwein, H P

“…Interleukin-6 (IL-6) is one of the major circulating cytokines in catabolic states. To investigate its endocrinologic and metabolic actions in vivo, we studied…”
Get full text

Effects of acute and chronic interleukin-6 administration on thyroid hormone metabolism in humans by Stouthard, J M, van der Poll, T, Endert, E, Bakker, P J, Veenhof, C H, Sauerwein, H P, Romijn, J A

“…Cytokines, such as tumor necrosis factor-alpha and interleukin-1 beta (IL-1 beta), alter thyroid hormone metabolism, and may be involved in the pathogenesis of…”
Get more information

Interleukin-6 stimulates coagulation, not fibrinolysis, in humans by Stouthard, J M, Levi, M, Hack, C E, Veenhof, C H, Romijn, H A, Sauerwein, H P, van der Poll, T

“…The role of IL-6 as a mediator of haemostatic changes during severe inflammation is controversial. To assess the effect of IL-6 on haemostasis we conducted a…”
Get more information

The Roter Interaction Analysis System (RIAS) in oncological consultations:: psychometric properties by Ong, L.M.L., Visser, M.R.M., Kruyver, I.P.M., Bensing, J.M., Van Den Brink-Muinen, A., Stouthard, J.M.L., Lammes, F.B., De Haes, J.C.J.M.

“…One of the most frequently used systems to analyse doctor–patient communication is the Roter Interaction Analysis System (RIAS). However, it has mostly been…”
Get full text

Interleukin-6 Enhances Glucose Transport in 3T3-L1 Adipocytes by Stouthard, J.M.L., Oude Elferink, R.P.J., Sauerwein, H.P.

“…To study the effect of interleukin-6 (IL-6) on glucose transport, 2-deoxy-D-glucose (2-DOG) uptake in 3T3-L1 adipocytes after incubation with IL-6 was…”
Get full text

Recombinant human interleukin 6 in metastatic renal cell cancer: a phase II trial by STOUTHARD, J. M. L, GOEY, H, DE VRIES, E. G. E, DE MULDER, P. H, GROENEWEGEN, A, PRONK, L, STOTER, G, SAUERWEIN, H. P, BAKKER, P. J. M, VEENHOF, C. H. N

“…A phase II trial investigating the anti-tumour effects of recombinant human interleukin 6 (rhIL-6) in patients with metastatic renal cell cancer was carried…”
Get full text

Endogenous interleukin 6 production in multiple myeloma patients treated with chimeric monoclonal anti-IL6 antibodies indicates the existence of a positive feed-back loop by van Zaanen, H C, Koopmans, R P, Aarden, L A, Rensink, H J, Stouthard, J M, Warnaar, S O, Lokhorst, H M, van Oers, M H

“…In vitro as well as in vivo observations have shown that IL6 plays a key role in the pathogenesis of multiple myeloma. Therefore we started a phase I/II dose…”
Get full text

Sex differences in the adaptation of glucose metabolism to short-term fasting: effects of oral contraceptives by Corssmit, E P, Stouthard, J M, Romijn, J A, Endert, E, Sauerwein, H P

“…The adaptation to long-term starvation is different in men and women. To evaluate whether there are also sex differences during short-term fasting (< 24…”
Get more information

Adaptive phase II randomized non-comparative trial of nivolumab after induction treatment in triple negative breast cancer: TONIC-trial by Kok, M., Horlings, H.M., van de Vijver, K., Wiersma, T., Russell, N., Voorwerk, L., Sikorska, K., van Werkhoven, E., Mandjes, I.A., Kemper, I., Foekema, J., Wilgenhof, S., Chalabi, M., Stouthard, J., Sonke, G.S., Cullen, D., Salgado, R., Schumacher, T.N.M., Blank, C.U., Linn, S.C.

Get full text

Infusion of Long-Chain or Medium-Chain Triglycerides Inhibits Peripheral Glucose Metabolism in Men by Stouthard, Jacqueune M.L., Endert, Erik, Romijn, Johannes A., Sauerwein, Hans P.

“…To investigate whether increased availability of lipids affects glucose metabolism in healthy postabsorptive men when lipid and glucose are infused in amounts…”
Get full text

Abstract P3-15-01: Primary G-CSF Prophylaxis during the First Two Cycles Only or Throughout All Chemotherapy Cycles in Breast Cancer Patients at Risk of Febrile Neutropenia: Final Results from a Phase III Trial of the Dutch Breast Cancer Trialists Group (BOOG) by Aarts, MJB, Peters, FPJ, Dercksen, WMW, Mandigers, CMPW, Stouthard, J, Nortier, HWR, Kamm, YJL, van Warmerdam, LJC, van der Rijt, CCD, van Gastel, S, Joore, M, Kessels, A, Tjan-Heijnen, VCG

“…Abstract Background: In patients at risk of febrile neutropenia (FN), the highest incidence of FN is seen during the first chemotherapy cycles. This…”
Get full text

Multicenter randomized phase III trial of 3-weekly paclitaxel/platinum (PC3w) versus weekly paclitaxel/platinum (PCw) induction therapy followed by PC3w maintenance therapy in advanced epithelial ovarian cancer (EOC) by Burg, M. E., Janssen, J. T., Ottevanger, P. B., Kerkhofs, L. G., Valster, F., Stouthard, J. M., Onstenk, W., Termorshuizen, F., Verweij, J.

“…Abstract only 5538 Background: Response rates (RR) up to 50% were found with PCw in platinum resistant EOC. We compared the efficacy of first-line PCw…”
Get full text

Randomized study comparing efficacy/toxicity of monotherapy trastuzumab followed by monotherapy docetaxel at progression, and combination trastuzumab/docetaxel as first-line chemotherapy in HER2-neu positive, metastatic breast cancer (MBC) (HERTAX study) by Bontenbal, M., Seynaeve, C., Stouthard, J., Bos, M., Braun, H., Erdkamp, F. L., van Deijk, G., Schmitz, P., Van der Stelt-Frissen, I., Hamberg, P., Klijn, J.

“…Abstract only…”
Get full text